Skip to main content
. 2020 Aug 10;22(9):1659–1665. doi: 10.1111/jch.13992

Table 1.

Baseline clinical characteristics of study patients

Characteristic

Total

(n = 2561)

Event (+)

(n = 69)

Event (−)

(n = 2492)

P value
Age, y 62.7 ± 11.7 65.8 ± 9.3 62.6 ± 11.8 .007
Female sex 1202 (46.9) 26 (37.7) 1176 (47.2) .118
BMI, kg/m2 25.4 ± 3.4 26.0 ± 3.5 25.4 ± 3.4 .147
SBP, mm Hg 138 ± 19 136 ± 20 138 ± 19 .540
DBP, mm Hg 81.2 ± 12.1 79.5 ± 10.8 81.3 ± 12.1 .231
Heart rate, per min 70.2 ± 12.5 69.7 ± 11.5 70.2 ± 12.5 .724
Cardiovascular risk factors
Obesity (BMI ≥ 25 kg/m2) 1320 (51.5) 41 (59.4) 1279 (51.3) .185
Diabetes mellitus 896 (35.0) 39 (56.5) 857 (34.4) <.001
Dyslipidemia 1682 (65.7) 57 (82.6) 1625 (65.2) .003
Cigarette smoking 406 (15.9) 16 (23.2) 390 (15.7) .091
Laboratory findings
WBC, per microliter 7191 ± 3647 7557 ± 2711 7180 ± 3669 .412
Hemoglobin, g/dL 13.3 ± 1.9 12.9 ± 2.5 13.3 ± 1.9 .191
GFR, mL/min/1.73 m2 80.7 ± 30.1 74.5 ± 36.8 80.9 ± 29.9 .159
Fasting glucose, mg/dL 124 ± 43 133 ± 53 123 ± 42 .146
Glycated hemoglobin, % 6.44 ± 1.12 6.89 ± 1.21 6.43 ± 1.11 .021
Total cholesterol, mg/dL 155 ± 39 142 ± 36 155 ± 39 .006
LDL cholesterol, mg/dL 87.8 ± 32.8 75.5 ± 33.6 88.1 ± 32.7 .003
HDL cholesterol, mg/dL 48.9 ± 12.9 47.5 ± 13.9 48.9 ± 12.9 .400
Triglycerides, mg/dL 129 ± 76 126 ± 61 129 ± 76 .719
C‐reactive protein, mg/dL 1.17 ± 3.66 1.92 ± 4.39 1.15 ± 3.64 .212
Concomitant medications
Calcium channel blocker 979 (38.2) 26 (37.7) 953 (38.2) .925
Beta blocker 800 (31.2) 29 (42.0) 771 (30.9) .050
RAS blocker 1284 (50.1) 34 (39.3) 1250 (50.2) .885
Diuretics 71 (2.8) 0 71 (2.8) .262
Statin 1467 (57.3) 52 (75.4) 1415 (56.8) .002

Numbers are expressed as mean ± standard deviation or n (%).

Abbreviations: BMI, body mass index; DBP, diastolic blood pressure; GFR, glomerular filtration rate; HDL, high‐density lipoprotein; LDL, low‐density lipoprotein; RAS, renin‐angiotensin system; SBP, systolic blood pressure; WBC, white blood cell.